Lord, Abbett & Co
MGNX icon

Lord, Abbett & Co’s MacroGenics MGNX Stock Holding History

Lord, Abbett & Co’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-281,307
Closed -$5.89M – 659
2021
Q3 		$5.89M Sell
281,307
-3,674
-1% -$88.5K 0.01% 578
2021
Q2 		$7.66M Buy
+284,981
New +$8.35M 0.02% 574
2019
Q3 		– Sell
-741,191
Closed -$12.6M – 749
2019
Q2 		$12.6M Buy
741,191
+97,321
+15% +$1.67M 0.04% 511
2019
Q1 		$11.6M Buy
+643,870
New +$11.1M 0.04% 533
2015
Q4 		– Sell
-29,089
Closed -$623K – 926
2015
Q3 		$623K Buy
+29,089
New +$912K ﹤0.01% 888

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Lord, Abbett & Co's MGNX Position: Q4 2021 in Review

Lord, Abbett & Co sold out of MacroGenics (MGNX) in Q4 2021, closing a stake of 281,307 shares — an estimated $5.89M sold.

Lord, Abbett & Co first reported a position in MGNX in Q3 2015 and held it in 5 quarters. The position peaked at $12.6M in Q2 2019. 156 funds tracked by Wall St. Rank hold MGNX as of Q4 2021.

  • Lord, Abbett & Co reported no remaining MacroGenics position as of Q4 2021 after selling out during the quarter.
  • Lord, Abbett & Co sold 281,307 MacroGenics shares in Q4 2021, an estimated $5.89M.
  • Lord, Abbett & Co first reported a position in MacroGenics in Q3 2015 and held it in 5 quarters.
  • Lord, Abbett & Co's MacroGenics position peaked at $12.6M in Q2 2019.
  • 156 funds tracked by Wall St. Rank held MacroGenics as of Q4 2021.

Based on Lord, Abbett & Co's 13F filing for Q4 2021, filed 11 Feb 2022.